Replies to post #476114 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

If Linda didn't reverse spit to keep the company off OTC then why would it be done now?

They said they would have R/S to stay on the NSDQ if needed.

But that was not an option as they were also being kicked out for governance issues prior to being kicked out for the $1 issue. And an R/S would not have mattered for that.

As far as now, they have authorized shares of 1.2B, but already over 1.5B fully diluted (and certain contracts that add more). They need to do something. Either raise the limit or R/S (and keep the limit the same)

Have no opinion on which option they chose. Nor do I care.

EDIT: She did R/S in 2012, I assume to stay listed. Also in 2007,.

[FeMike]

If Linda didn't reverse spit to keep the company off OTC then why would it be done now?

Two reasons.

First, at the time less regulation was actually good for the company. And I don't mean this in a nefarious way. It's just true.

Second, she didn't have an issue with AS/OS when they got delisted. She does now. An RS would solve those issues. It's not just for uplisting purposes.

[BetIsOn]

If company took the advice to RS, you will be crying right now. The price will be shorted back to right where you are, but your shares are many times less. Right now there are about 10M warrants exercised each month. Should be able to last for a while.

[biosectinvestor]

People talking R/S without the company proposing it are just trying to keep anyone from buying right now. Common trick when nothing else will work. There is no discussion at this time if a r/s and more likely we’ll see partnerships or the sale of the company.